Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol

Detalhes bibliográficos
Ano de defesa: 2022
Autor(a) principal: Silva, Keilla Façanha
Orientador(a): Ayala, Alejandro Pedro
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://www.repositorio.ufc.br/handle/riufc/69671
Resumo: The therapeutic efficacy of drugs is directly related to their physicochemical characteristics, which, in turn, are linked to the structural arrangement they present. They are derived from the different conformations and intramolecular and intermolecular interactions that define the crystalline packing of molecules in different solid forms. The objective of the present work was to develop multicomponent solids for the active pharmaceutical ingredients (APIs) ondansetron hydrochloride (ODT) and ricobendazole (RBZ). For this, crystal engineering strategies were adopted, combining the functional groups of APIs with functional groups of coformers, which formed supramolecular synthons by intermolecular hydrogen interactions. Ondansetron hydrochloride is a drug administered to control side effects induced by the cytotoxic character in chemotherapy and radiotherapy treatments. It has high aqueous solubility, but producing a cocrystal with low solubility may be an option for a slow and sustained release of the active ingredient. For this compound, we obtained four new structures. Ricobendazole is a drug widely used to prevent and treat parasitic diseases. It has low aqueous solubility causing low bioavailability, which motivated us to search for new structures such as cocrystals and salts. The preparation methods induced the formation of five new crystal structures. In addition, we elucidate and characterize its crystalline structure since no structural information is reported in the literature. The methods applied to obtain the new solid forms were mechanochemical activation, slurry, and slow evaporation of the solvent. Single crystal X-ray diffraction was used for structural elucidation, while characterization was performed by powder X-ray diffraction, vibrational spectroscopy in the infrared region, and thermal analysis by thermogravimetry and differential scanning calorimetry techniques. The solubility test was also performed, aiming to compare the profile of the new solid forms with the commercially available form.
id UFC-7_86aec97aa74830254529af27f43db090
oai_identifier_str oai:repositorio.ufc.br:riufc/69671
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Silva, Keilla FaçanhaAyala, Alejandro Pedro2022-12-06T19:46:38Z2022-12-06T19:46:38Z2022SILVA, K. F. Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol. 2022. 97 f. Tese (Doutorado em Física) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2022.http://www.repositorio.ufc.br/handle/riufc/69671The therapeutic efficacy of drugs is directly related to their physicochemical characteristics, which, in turn, are linked to the structural arrangement they present. They are derived from the different conformations and intramolecular and intermolecular interactions that define the crystalline packing of molecules in different solid forms. The objective of the present work was to develop multicomponent solids for the active pharmaceutical ingredients (APIs) ondansetron hydrochloride (ODT) and ricobendazole (RBZ). For this, crystal engineering strategies were adopted, combining the functional groups of APIs with functional groups of coformers, which formed supramolecular synthons by intermolecular hydrogen interactions. Ondansetron hydrochloride is a drug administered to control side effects induced by the cytotoxic character in chemotherapy and radiotherapy treatments. It has high aqueous solubility, but producing a cocrystal with low solubility may be an option for a slow and sustained release of the active ingredient. For this compound, we obtained four new structures. Ricobendazole is a drug widely used to prevent and treat parasitic diseases. It has low aqueous solubility causing low bioavailability, which motivated us to search for new structures such as cocrystals and salts. The preparation methods induced the formation of five new crystal structures. In addition, we elucidate and characterize its crystalline structure since no structural information is reported in the literature. The methods applied to obtain the new solid forms were mechanochemical activation, slurry, and slow evaporation of the solvent. Single crystal X-ray diffraction was used for structural elucidation, while characterization was performed by powder X-ray diffraction, vibrational spectroscopy in the infrared region, and thermal analysis by thermogravimetry and differential scanning calorimetry techniques. The solubility test was also performed, aiming to compare the profile of the new solid forms with the commercially available form.A eficácia terapêutica dos fármacos está diretamente relacionada à suas características físico-químicas, que, por sua vez, estão vinculadas ao arranjo estrutural que eles apresentam, no qual são derivados das diferentes conformações e/ou interações intramoleculares e intermoleculares que definem o empacotamento cristalino das moléculas nas diferentes formas sólidas. O objetivo do presente trabalho foi desenvolver sólidos multicomponentes para os ingredientes farmacêuticos ativos (IFAs) cloridrato de ondansentrona (ODTCl) e ricobendazol (RBZ). Para isso foram adotadas estratégias da engenharia de cristais, onde estas estratégias combinaram os grupos funcionais dos IFAs a grupos funcionais de coformadores, que formaram synthons supramoleculares por interações intermoleculares de hidrogênio. O cloridrato de ondansetrona é um fármaco administrado no controle dos efeitos colaterais induzidos pelo caráter citotóxico nos tratamentos quimioterápicos e radioterápicos. Ele apresenta alta solubilidade aquosa, porém a produção de um cocristal com baixa solubilidade pode ser uma opção para uma liberação lenta e sustentada do princípio ativo. Para esse composto, obtivemos quatro novas estruturas. O ricobendazol é um fármaco amplamente utilizado para a prevenção e tratamento de doenças parasitárias. Ele possui baixa solubilidade aquosa causando uma baixa biodisponibilidade, o que nos motivou a buscar por novas estruturas como cocristais e sais. Os métodos de preparação utilizados neste trabalho permitiram a obtenção de cinco novas estruturas cristalinas. Além disso, elucidamos e caracterizamos sua estrutura cristalina, já que não há informações estruturais relatadas da literatura. Os métodos aplicados para obtenção das novas formas sólidas foram ativação mecanoquímica, slurry e evaporação lenta de solvente. A difração de raios-X de monocristal foi utilizada para elucidação estrutural, enquanto a caracterização foi realizada por difração de raios-X de pó, espectroscopia vibracional na região do infravermelho e análise térmica pelas técnicas de termogravimetria e calorimetria exploratória diferencial. O teste de solubilidade também foi realizado, visando comparar o perfil das novas formas sólidas com a forma comercialmente disponível.Cloridrato de ondansetronaRicobendazolSólidos multicomponentesCocristaisSaisDesenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazolinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccessORIGINAL2022_tese_kfsilva.pdf2022_tese_kfsilva.pdfapplication/pdf2629845http://repositorio.ufc.br/bitstream/riufc/69671/5/2022_tese_kfsilva.pdf4210ffe21d6268b6653ec801b3df0121MD55LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.ufc.br/bitstream/riufc/69671/6/license.txt8a4605be74aa9ea9d79846c1fba20a33MD56riufc/696712022-12-06 16:46:38.95oai:repositorio.ufc.br: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Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2022-12-06T19:46:38Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.pt_BR.fl_str_mv Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
title Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
spellingShingle Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
Silva, Keilla Façanha
Cloridrato de ondansetrona
Ricobendazol
Sólidos multicomponentes
Cocristais
Sais
title_short Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
title_full Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
title_fullStr Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
title_full_unstemmed Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
title_sort Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol
author Silva, Keilla Façanha
author_facet Silva, Keilla Façanha
author_role author
dc.contributor.author.fl_str_mv Silva, Keilla Façanha
dc.contributor.advisor1.fl_str_mv Ayala, Alejandro Pedro
contributor_str_mv Ayala, Alejandro Pedro
dc.subject.por.fl_str_mv Cloridrato de ondansetrona
Ricobendazol
Sólidos multicomponentes
Cocristais
Sais
topic Cloridrato de ondansetrona
Ricobendazol
Sólidos multicomponentes
Cocristais
Sais
description The therapeutic efficacy of drugs is directly related to their physicochemical characteristics, which, in turn, are linked to the structural arrangement they present. They are derived from the different conformations and intramolecular and intermolecular interactions that define the crystalline packing of molecules in different solid forms. The objective of the present work was to develop multicomponent solids for the active pharmaceutical ingredients (APIs) ondansetron hydrochloride (ODT) and ricobendazole (RBZ). For this, crystal engineering strategies were adopted, combining the functional groups of APIs with functional groups of coformers, which formed supramolecular synthons by intermolecular hydrogen interactions. Ondansetron hydrochloride is a drug administered to control side effects induced by the cytotoxic character in chemotherapy and radiotherapy treatments. It has high aqueous solubility, but producing a cocrystal with low solubility may be an option for a slow and sustained release of the active ingredient. For this compound, we obtained four new structures. Ricobendazole is a drug widely used to prevent and treat parasitic diseases. It has low aqueous solubility causing low bioavailability, which motivated us to search for new structures such as cocrystals and salts. The preparation methods induced the formation of five new crystal structures. In addition, we elucidate and characterize its crystalline structure since no structural information is reported in the literature. The methods applied to obtain the new solid forms were mechanochemical activation, slurry, and slow evaporation of the solvent. Single crystal X-ray diffraction was used for structural elucidation, while characterization was performed by powder X-ray diffraction, vibrational spectroscopy in the infrared region, and thermal analysis by thermogravimetry and differential scanning calorimetry techniques. The solubility test was also performed, aiming to compare the profile of the new solid forms with the commercially available form.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-12-06T19:46:38Z
dc.date.available.fl_str_mv 2022-12-06T19:46:38Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA, K. F. Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol. 2022. 97 f. Tese (Doutorado em Física) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2022.
dc.identifier.uri.fl_str_mv http://www.repositorio.ufc.br/handle/riufc/69671
identifier_str_mv SILVA, K. F. Desenvolvimento e caracterização de novas formas sólidas multicomponentes do cloridrato de ondansetrona e ricobendazol. 2022. 97 f. Tese (Doutorado em Física) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2022.
url http://www.repositorio.ufc.br/handle/riufc/69671
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
bitstream.url.fl_str_mv http://repositorio.ufc.br/bitstream/riufc/69671/5/2022_tese_kfsilva.pdf
http://repositorio.ufc.br/bitstream/riufc/69671/6/license.txt
bitstream.checksum.fl_str_mv 4210ffe21d6268b6653ec801b3df0121
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1847793190796525568